Imaging Compound May Catch Early Alzheimer’s
Forbes - WEDNESDAY, Dec. 20 (HealthDay News) — A new imaging technique could make it possible for doctors to detect Alzheimer’s disease in the brain before extensive damage has taken place, researchers report. A study in the Dec. 21 issue of the New England
Siemens and UCLA Researchers Get FDA ‘’Green Light'’ for Clinical
MSN MoneyCentral - Solutions announced today that it will begin clinical trials under an investigational new drug (IND) application submitted to the Food and Drug Administration (FDA) for a breakthrough imaging biomarker that could potentially identify Alzheimer’s
Cornell Gets $15 Million to Research Alzheimer’s (Update1)
Bloomberg - Dec. 19 (Bloomberg) — Cornell University’s medical school received a $15 million donation from former Neuberger Berman managing director Robert Appel to establish a research center for Alzheimer’s disease. The Appel Institute for Alzheimer’s
Brain Scanning Technology May Identify Alzheimer’s
KCBD - Scientists at UCLA may have discovered a way to spot early stages of Alzheimer’s Disease years before symptoms show up. The study in Thursday’s edition of the New England Journal of Medicine shows the use of brain scanning technology may help
Biotech firm gets rights to drug
San Francisco Gate - This month, Genentech agreed to work with AC Immune Ltd., a 3-year-old Swiss company, to develop a drug to treat Alzheimer’s disease. Altus, which has a second product in clinical trials and is still unprofitable, turned to Genentech because of
Neuralstem set for OTC listing
Baltimore Sun - decade ago, has developed technology to isolate and multiply neural stem cells in commercial-sized quantities as well as control their development into particular cells, which it believes could be used to treat various diseases, including Alzheimer’s